Skip to content

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

Technology Assisted Intervention for the Treatment and Prevention of Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841787
Acronym
MoodTech
Enrollment
47
Registered
2016-07-22
Start date
2015-12-31
Completion date
2016-09-30
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Web-based intervention, Aging, Geriatrics, Social network, Older adults

Brief summary

The goal of this field trial is to tailor and test a web-based intervention in adults 65 years of age or older. Two versions of the web-based intervention have been created and will be tested--one with an online social network and one without an online social network. The purpose of this study is to: pilot a novel intervention, examine methods to improve adherence to web-based interventions (e.g., peer network); collect data on feasibility, acceptability, and efficacy of an web-based intervention for late life depression; and ultimately, to overcome the numerous barriers to treating depression in later life.

Interventions

BEHAVIORALiCBT for late life depression

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has elevated depressive symptoms * Has a telephone, e-mail account, computer, and broadband access to the Internet. * Has basic internet skills and is able to access the internet independently * Is able to speak and read English. * Is at least 65 years of age. * Is able to give informed consent.

Exclusion criteria

* Has hearing or voice impairment that would prevent participation in psychotherapy * Has visual impairment that would prevent completion of assessment materials. * Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance abuse, or other diagnosis for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous. * Is currently receiving individual psychotherapy or planning to receive psychotherapy during the 8-week treatment phase of the study * Is planning to be out of town or unavailable for an extended period of time during the study without access to the Internet * Exhibits severe suicidality, including ideation, plan, and intent. * Has initiated treatment with an antidepressant in past 14 days. Once patients have been on a stable dose for 14 days and do not have an appointment with a physician or psychiatrist to change this dose, the patient will be eligible based on this criterion.

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity ModuleBaseline and Week 8 - Difference in PHQ-9 scoreThe PHQ-9 measures degree of depression severity. Possible range of scores for the PHQ-9 is 0-27. Higher values represent a worse outcome. Specifically, scores of 0-4 indicate minimal or no depression; 5-9 is mild; 10-14 is moderate; 15-19 is moderately severe; and 20-27 is severe. The data table below shows PHQ-9 pre- and post- intervention score differences by group.
Mean Number of Sessions Across the 8-week Trial8 weeks
System Usability Scale (SUS)Week 8The System Usability Scale (SUS) is a usability scale that can be used for global assessments of systems usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows you to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. A SUS score above a 68 would be considered above average and anything below 68 is below average.
Average Coaching Time Per Participant by Group8 weeksThe average time spent on messages and calls and on group moderation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Individual Internet Intervention (III)
Coached internet intervention based on the principles of cognitive behavioral therapy (CBT) for depressed older adults delivered individually by 2 clinical psychologists.
12
Internet Intervention With Peer Support (II+PS)
Coached internet intervention based on the principles of cognitive behavioral therapy (CBT) for depressed older adults delivered with peer support; group moderation was provided by 2 clinical psychologists.
23
Waitlist Control (WLC)
WLC participants received access to the III following the 8-week waiting period.
12
Total47

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up100
Overall StudySymptoms dropped below threshold100
Overall StudyWithdrawal by Subject140

Baseline characteristics

CharacteristicIndividual Internet Intervention (III)Internet Intervention With Peer Support (II+PS)Waitlist Control (WLC)Total
Age, Continuous69.2 years
STANDARD_DEVIATION 3.4
69.5 years
STANDARD_DEVIATION 4.3
70 years
STANDARD_DEVIATION 4.7
69.6 years
STANDARD_DEVIATION 4.1
Annual gross household income (x1000)37.5 USD37 USD50 USD41 USD
Education
2-yr College (Associate's)
0 Participants5 Participants2 Participants7 Participants
Education
4-yr College (Bachelor's)
3 Participants6 Participants4 Participants13 Participants
Education
Doctoral Degree (PhD, MD, JD)
3 Participants2 Participants2 Participants7 Participants
Education
Master's Degree
5 Participants5 Participants2 Participants12 Participants
Education
Some College
1 Participants5 Participants1 Participants7 Participants
Education
Some High School
0 Participants0 Participants1 Participants1 Participants
Employment Status
Employed
3 Participants4 Participants3 Participants10 Participants
Employment Status
Retired
9 Participants18 Participants7 Participants34 Participants
Employment Status
Unemployed/Disability
0 Participants1 Participants2 Participants3 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants22 Participants12 Participants46 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Health Insurance
Insured
12 Participants22 Participants12 Participants46 Participants
Health Insurance
Medicaid
1 Participants3 Participants0 Participants4 Participants
Health Insurance
Medicare
10 Participants19 Participants11 Participants40 Participants
Marital Status
No Partner
8 Participants16 Participants5 Participants29 Participants
Marital Status
Partner
4 Participants7 Participants7 Participants18 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants0 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
11 Participants19 Participants11 Participants41 Participants
Sex: Female, Male
Female
8 Participants16 Participants8 Participants32 Participants
Sex: Female, Male
Male
4 Participants7 Participants4 Participants15 Participants
Taking antidepressant medication
No
7 Participants18 Participants7 Participants32 Participants
Taking antidepressant medication
Yes
5 Participants5 Participants5 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 230 / 12
other
Total, other adverse events
0 / 120 / 230 / 12
serious
Total, serious adverse events
0 / 120 / 230 / 12

Outcome results

Primary

Average Coaching Time Per Participant by Group

The average time spent on messages and calls and on group moderation.

Time frame: 8 weeks

Population: Participants were included in outcome analyses if they completed assessments at both baseline and week 8; for the Individual Internet Intervention (III) arm, 9 participants met this criterion, and for Internet Intervention with Peer Support (II+PS), 19 participants met this criterion.

ArmMeasureValue (MEAN)Dispersion
Individual Internet Intervention (III)Average Coaching Time Per Participant by Group134.33 MinutesStandard Deviation 28.43
Internet Intervention With Peer Support (II+PS)Average Coaching Time Per Participant by Group92.43 MinutesStandard Deviation 32.36
p-value: 0.003t-test, 2 sided
Primary

Mean Number of Sessions Across the 8-week Trial

Time frame: 8 weeks

Population: Out of the 12 participants who started Individual Internet Intervention, one participant was administratively dropped (no longer eligible for the study) before treatment started; only 11 participants were analyzed.

ArmMeasureValue (MEAN)Dispersion
Individual Internet Intervention (III)Mean Number of Sessions Across the 8-week Trial45.6 number of sessionsStandard Deviation 24.9
Internet Intervention With Peer Support (II+PS)Mean Number of Sessions Across the 8-week Trial49.1 number of sessionsStandard Deviation 35.8
Primary

Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module

The PHQ-9 measures degree of depression severity. Possible range of scores for the PHQ-9 is 0-27. Higher values represent a worse outcome. Specifically, scores of 0-4 indicate minimal or no depression; 5-9 is mild; 10-14 is moderate; 15-19 is moderately severe; and 20-27 is severe. The data table below shows PHQ-9 pre- and post- intervention score differences by group.

Time frame: Baseline and Week 8 - Difference in PHQ-9 score

ArmMeasureValue (MEAN)Dispersion
Individual Internet Intervention (III)Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module-5.4 units on a scaleStandard Deviation 2.4
Internet Intervention With Peer Support (II+PS)Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module-4.8 units on a scaleStandard Deviation 4.4
Waitlist Control (WLC)Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module-1.1 units on a scaleStandard Deviation 4.7
p-value: <0.001t-test, 2 sided
p-value: <0.001t-test, 2 sided
p-value: 0.44t-test, 2 sided
p-value: 0.03ANOVA
p-value: 0.68t-test, 2 sided
p-value: 0.02t-test, 2 sided
p-value: 0.03t-test, 2 sided
Primary

System Usability Scale (SUS)

The System Usability Scale (SUS) is a usability scale that can be used for global assessments of systems usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows you to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. A SUS score above a 68 would be considered above average and anything below 68 is below average.

Time frame: Week 8

Population: Participants were included in outcome analyses if they completed assessments at both baseline and week 8; for the Individual Internet Intervention (III) arm, 9 participants met this criterion, and for Internet Intervention with Peer Support (II+PS), 21 participants met this criterion.

ArmMeasureValue (MEAN)Dispersion
Individual Internet Intervention (III)System Usability Scale (SUS)68.75 units on a scaleStandard Deviation 16.09
Internet Intervention With Peer Support (II+PS)System Usability Scale (SUS)60.5 units on a scaleStandard Deviation 16.69

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026